Workflow
BlueLinx (BXC) - 2024 Q1 - Quarterly Results

Financial Performance - Net sales for Q1 2024 were 726million,withagrossprofitof726 million, with a gross profit of 128 million and a gross margin of 17.6%[2]. - Adjusted EBITDA for the quarter was 39million,representing5.339 million, representing 5.3% of net sales, benefiting from approximately 7 million related to import duties from prior periods[2][11]. - Net income was 17million,or17 million, or 2.00 diluted earnings per share, compared to 18million,or18 million, or 1.94 per diluted share in the prior year[5]. - For the first quarter of 2024, net sales were 726million,adecreaseof726 million, a decrease of 72 million, or 9.0% compared to the first quarter of 2023[39]. - Gross profit for the first quarter was 128million,down128 million, down 6 million, or 4.4% year-over-year, with a gross margin of 17.6%, an increase of 90 basis points from the same period last year[39]. - Adjusted EBITDA was 39million,or5.339 million, or 5.3% of net sales, compared to 47 million, or 5.9% of net sales in the first quarter of 2023[41]. - Basic earnings per share (EPS) for the first quarter was 2.02,comparedto2.02, compared to 1.96 in the same period last year[34]. - Diluted EPS for the first quarter was 2.00,comparedto2.00, compared to 1.94 in the same period last year[34]. - Adjusted net income was 19million,or19 million, or 2.14 per diluted share, down from 23million,or23 million, or 2.53 per diluted share in the prior year[5]. - Net income for the three months ended March 30, 2024, was 17,492,comparedto17,492, compared to 17,812 for the same period last year, a decrease of 1.8%[58]. - Adjusted EBITDA margin decreased to 5.3% from 5.9% year-over-year, reflecting a decline in profitability[63]. - Total net sales for the three months ended March 30, 2024, were 726,244,downfrom726,244, down from 797,904, a decrease of 8.9%[66]. Specialty Products - Net sales of specialty products decreased by 64million,or1164 million, or 11%, to 504 million, while gross margin improved to 20.7% from 18.8% in the prior year[12]. - The decline in specialty product sales was attributed to deflationary impacts across several categories[12]. - Specialty products gross margin improved to 20.7% from 18.8% year-over-year, indicating better cost management in this category[66]. - Specialty product gross margin for the first four weeks of the second quarter of 2024 was in the range of 18% to 19%[43]. Cash Flow and Liquidity - Net cash used in operating activities was 31million,asignificantdecreasefrom31 million, a significant decrease from 89 million of net cash provided in the prior year[14]. - Available liquidity stood at 828million,including828 million, including 481 million in cash and cash equivalents[2][15]. - The company reported strong liquidity, allowing for flexibility in pursuing strategic initiatives and returning capital to shareholders[38]. - Free cash flow for the three months ended March 30, 2024, was (36,582),comparedto(36,582), compared to 79,957 for the same period last year, showing a significant decline[72]. - Cash and cash equivalents at the end of the period were 481,309,downfrom481,309, down from 521,743, a decrease of 7.7%[58]. Debt and Liabilities - The company reported a net debt of (133)million,resultinginanetleverageratioof(0.8x)ontrailingtwelvemonthAdjustedEBITDAof133) million, resulting in a net leverage ratio of (0.8x) on trailing twelve-month Adjusted EBITDA of 175 million[15]. - Total liabilities increased to 938,424from938,424 from 903,315, an increase of 3.9%[57]. - Net debt, excluding cash and cash equivalents, was 110,758,downfrom110,758, down from 194,530 year-over-year, indicating improved leverage[64]. Operational Expenses and Investments - Selling, general and administrative (SG&A) expenses were 91millioninthefirstquarter,consistentwiththeprioryearperiod[40].Thecompanyinvested91 million in the first quarter, consistent with the prior year period[40]. - The company invested 5 million in capital improvements during the first quarter, down from 9millioninthesameperiodlastyear[42].Thecompanyhas9 million in the same period last year[42]. - The company has 91.4 million remaining under its share repurchase authorization[42]. Accounts Receivable - Accounts receivable increased to 288,244from288,244 from 228,410, reflecting a rise of 26.2%[57].